Market Tracker

02/12 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

18.97
Delayed Data
As of Feb 12
 +0.06 / +0.32%
Today’s Change
15.92
Today|||52-Week Range
32.49
-21.48%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close18.91
Today’s open19.13
Day’s range18.25 - 19.93
Volume708,865
Average volume (3 months)869,486
Market cap$728.9M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+4.64%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book4.97

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.37+1.99%
ZIOPZIOPHARM Oncology In...+0.10+1.82%
RGENRepligen Corp+1.24+5.71%
CLLSCellectis SA+0.15+0.78%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 1, 2016
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts